MacroGenics | MGNX - Прибыль до налогообложения





Прибыль до налогообложения Изменить Дата
AbbVie USD 7.61B 2.04B 2026-06
Amgen USD 2.08B 570M 2026-03
AstraZeneca USD 4.81B 894M 2026-06
Biogen USD 647.3M 269.6M 2026-06
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Daiichi Sankyo JPY -6.52B 113.25B 2026-03
Eli Lilly USD 8.85B 583.8M 2026-03
Genmab DKK 295M 221M 2026-06
Geron USD -3.64M 27.5M 2026-03
Gilead Sciences USD -7.53B 10.11B 2026-06
J&J USD 8.66B 839M 2026-06
Karyopharm Therapeutics USD -22.39M 17.51M 2026-03
MacroGenics USD -36.77M 21.84M 2026-03
Merck USD -3.53B 6.95B 2026-03
Pfizer USD -653M 5.84B 2026-06
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.53B 696.6M 2026-06
Roche Holding CHF 11.17B 6.38B 2026-06
Xencor USD -21.92M 106.72M 2026-06